What We Don't Hear About GLP-1s: Mental Health & Identity with Kate Lyman
Update: 2025-10-22
Description
Are you considering GLP-1 medications like Semaglutide, Tirzepatide, or Zepbound for weight loss, or do you know someone who is? This conversation provides a nuanced conversation about GLP-1s and considerations around starting them.
In this episode, host Nikki Naab-Levy chats with Kate Lyman, a nutrition coach with a Master's in public health about the unspoken potential ramifications of using these drugs, from a mental health and behavior change perspective.
In this episode, you'll learn:
- The difference between the clinical and social media definitions of "food noise".
- Why weight loss on a GLP-1 does not automatically equate to better body image or health.
- The potential for GLP-1s to replace "food noise" with new fixations or obsessions in (e.g., scale-watching, body composition) in some individuals.
- The mixed mental health outcomes of GLP-1s, including studies linking them to an elevated risk of anxiety, major depression, and suicidal behavior in some populations, while others (like those with binge eating disorder) may see positive benefits.
- Recommended lifestyle support and interventions that can be used alongside medication to ensure fat loss while protecting and maintaining muscle mass and bone density.
- <span style="font-size: 11pt; font-family: 'Google Sans Text',sans-serif; color: #000000; background-c
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
